HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Salon Selectives Fashion-Inspired Hair Care Revamp Set For September

This article was originally published in The Rose Sheet

Executive Summary

The venerable Salon Selectives hair care brand has been reinvented with new salon-inspired formulas, milder fragrances and hip packaging, Helene Curtis said. The most complete revamp since the brand's 1987 debut, 26 new products will replace the original SKUs in September.

You may also be interested in...



Marketing In Brief

Neutrogena: Visibly Firm skin care extended with Face Lotion SPF 20 and Body Lotion, which contain brand's Active Copper technology, Johnson & Johnson division says. Formulated with broad spectrum UVA/UVB sunscreen protection, Face Lotion "helps restore skin's firmness" and elasticity for noticeable results after one week of daily use, Neutrogena claims. Applied twice a day, Body Lotion provides "more toned, resilient" skin with improved texture in two weeks, firm says. Bowing now, 1.7 oz. face and 8.5 oz. body items retail for $19 and $9.99, respectively. Visibly Firm debuted last year and comprises six items including eye treatment products and makeup (1"The Rose Sheet" Feb. 26, 2001, p. 4)...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel